This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major

Sponsored by Indonesia University

About this trial

Last updated 7 years ago

Study ID

NSovira

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

5 to 18 Years
All Sexes

Trial Timing

Ended 9 years ago

What is this trial about?

The accumulation of unpaired α-globin chains in β-thalassemia major patients may clinically create ineffective erythropoiesis, hemolysis, and chronic anemia. Multiple blood transfusions and iron overload cause cellular oxidative damage. However, α-tocopherol, an antioxidant, has been known as a potent scavenger of lipid radicals in the red cell membrane of β-thalassemia major patient. By this randomized controlled trial, the investigators would like to evaluate the effects of α-tocopherol in hemolysis and oxidative stress on the red cell membrane of β-thalassemia major.

What are the participation requirements?

Inclusion Criteria

* received frequent transfusions,

* iron chelation

* aged 5 - 18-year-olds

* with no other hematologic disorders

* does not consume any other antioxidants or herbal supplements

Exclusion Criteria

* the acute or chronic infection including hepatitis B or hepatitis C,

* splenectomy

* liver failure

* abnormality level of lipid test